Importância do diagnóstico precoce do câncer colorretal em pacientes com síndrome metabólica
##plugins.themes.bootstrap3.article.sidebar##
##plugins.themes.bootstrap3.article.main##
Resumo
Objetivo: Identificar na literatura a correlação da síndrome metabólica (SM) com o câncer colorretal (CCR), elucidando a importância do diagnóstico precoce. Métodos: Trata-se de uma Revisão Integrativa da Literatura, acerca do diagnóstico precoce do câncer colorretal em pacientes com síndrome metabólica. As bases de dados pesquisadas foram Pubmed e Scielo, com a inclusão dos seguintes indexadores: "Early Diagnosis" AND "Colorectal Neoplasms" AND "Metabolic Syndrome". Resultados: No total, foram obtidos 6 artigos que obedeceram aos critérios de inclusão e exclusão: Após as buscas nos bancos de dados, os estudos demonstraram que o aumento de casos de CCR é, também, devido ao número crescente de jovens com síndrome metabólica e outras condições metabólicas pró-inflamatórias. Considerações finais: O CCR é uma das malignidades mais comuns, com mais morbimortalidade ao redor do mundo e tem como um dos seus principais fatores de risco a Síndrome Metabólica. A alta prevalência da Síndrome Metabólica desempenha um papel crucial no aumento dos casos de CCR, pois está atrelada a uma dieta inadequada com baixo consumo de frutas, fibras e vegetais e com alto consumo de ultraprocessados ligados ao sedentarismo e obesidade.
##plugins.themes.bootstrap3.article.details##
Copyright © | Todos os direitos reservados.
A revista detém os direitos autorais exclusivos de publicação deste artigo nos termos da lei 9610/98.
Reprodução parcial
É livre o uso de partes do texto, figuras e questionário do artigo, sendo obrigatória a citação dos autores e revista.
Reprodução total
É expressamente proibida, devendo ser autorizada pela revista.
Referências
2. CHENG WC, et al. Age, male sex, smoking and metabolic syndrome as risk factors of advanced colorectal neoplasia for fecal immunochemical test negative patients. Journal of the Formosan Medical Association, 2022; 121(1).
3. CHOI YJ, et al. Optimal Starting Age for Colorectal Cancer Screening in an Era of Increased Metabolic Unhealthiness: A Nationwide Korean Cross-Sectional Study. Gut Liver, 2018; 12(6): 655-663.
4. CHUNG KC, et al. Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study. BMC Gastroenterology, 2022;
5. FENG Q, et al. Risk of death in colorectal cancer patients with multi-morbidities of metabolic syndrome: A retrospective multicohort analysis. Cancer Research and Treatment, 2021; 53(3).
6. HAN F, et al. The association of metabolic syndrome and its components with the incidence and survival of colorectal cancer: A systematic review and meta-analysis. International Journal of Biological Sciences, 2021; 17(3).
7. HARLID S, et al. The metabolic syndrome, inflammation, and colorectal cancer risk: An evaluation of large panels of plasma protein markers using repeated, prediagnostic samples. Mediators of Inflammation, 2017; 2017.
8. HE Q, et al. A study on relationship between metabolic syndrome and colorectal cancer. J BUON, 2018; 23(5).
9. KARRA P, et al. Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome. Obesity (Silver Spring), 2022; 30(7): 1323-1334.
10. LESKO J, et al. Association of colorectal carcinoma and metabolic syndrome. Med Glas (Zenica), 2020; 17(1): 151-157.
11. LI Y, et al. Clinical and genomic characteristics of metabolic syndrome in colorectal cancer. Aging (Albany NY), 2021;
12. LIU T, et al. The combination of metabolic syndrome and inflammation increased the risk of colorectal cancer. Inflammation Research, 2022 Aug;
13. LU B, QIAN JM, LI JN. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review. J Gastroenterol Hepatol, 2023; 38(2): 187-196.
14. SUCHANEK S, et al. How significant is the association between metabolic syndrome and prevalence of colorectal neoplasia? World J Gastroenterol, 2016; 22(36): 8103-8111.
15. TAMAI R, et al. The association of metabolic risk factors with advanced adenomas in Hispanic patients. Dig Dis Sci, 2024; 69(4): 1403-1410.
16. TRABULO D, et al. Metabolic syndrome and colorectal neoplasms: An ominous association. World J Gastroenterol, 2015; 21(17): 5320-5327.
17. VARGAS T, et al. Genes associated with metabolic syndrome predict disease-free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer. Molecular Oncology, 2014; 8(8).
18. WU PN, et al. Global trends in colorectal cancer and metabolic syndrome research: A bibliometric and visualization analysis. Int J Surg, 2024; 110(6): 3723-3733.
19. YEH JH, et al. Positive fecal immunochemical test strongly predicts adenomas in younger adults with fatty liver and metabolic syndrome. Clin Transl Gastroenterol, 2021; 12(2): e00305.
20. ZHANG C, et al. Association between metabolic syndrome and early-stage colorectal cancer. BMC Cancer, 2023; 23(1): 1020.